scispace - formally typeset
L

Libera Sessa

Researcher at University of Rome Tor Vergata

Publications -  6
Citations -  871

Libera Sessa is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Immune system & B cell. The author has an hindex of 5, co-authored 5 publications receiving 452 citations. Previous affiliations of Libera Sessa include Ragon Institute of MGH, MIT and Harvard.

Papers
More filters
Journal ArticleDOI

Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART.

TL;DR: An overview of the most recent data about HIV-associated inflammation and chronic immune exhaustion in PLWH under effective ART is provided and new therapy approaches that are currently being tested to reduce the risk of developing inflammation, ART toxicity, and non-AIDS co-morbidities are discussed.
Journal ArticleDOI

The Loss of Bcl-6 Expressing T Follicular Helper Cells and the Absence of Germinal Centers in COVID-19

TL;DR: Analysis of postmortem thoracic lymph nodes and spleens in acute SARS-CoV-2 infection identifies defective Bcl-6+TFH cell generation and dysregulated humoral immune induction early in COVID-19 disease, providing a mechanistic explanation for the limited durability of antibody responses in coronavirus infections and suggest that achieving herd immunity through natural infection may be difficult.
Journal ArticleDOI

Olea europaea small RNA with functional homology to human miR34a in cross-kingdom interaction of anti-tumoral response

TL;DR: The results indicate the possibility of developing novel natural non-toxic drugs that contain active plant-derived tumor-suppressing small RNA with functional homology to hsa-miRNAs and that can support antineoplastic strategies.
Journal ArticleDOI

Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.

TL;DR: In this paper, the authors investigated the correlation between the gut microbiota profile, markers of inflammation, vascular endothelial activation (VEA) and microbial translocation (MT) in perinatally HIV-infected patients (PHIV) under ART.